Healthcare Distribution Alliance – Patients Move Us.
Share Print
News

News

HDA Statement on Senate Passage of Legislation to Address Opioid Abuse Epidemic

September 17, 2018

ARLINGTON, Va. — Healthcare Distribution Alliance (HDA) President and CEO John M. Gray released the following statement on the Senate passage of comprehensive opioid legislation, the SUPPORT for Patients and Communities Act (H.R. 6).

“We applaud the bipartisan passage of this legislation, which represents a comprehensive approach and critical step forward in advancing meaningful solutions to the opioid crisis.

“To strengthen and improve communication between distributors and the DEA, HDA and its members strongly support two core provisions — Sec. 3202, sponsored by Sens. Feinstein (D-Calif.), Grassley (R-Iowa), Capito (R. W.Va.) and Durbin (D-Ill.); and Sec. 3602, sponsored by Sens. Hassan (D-N.H.) and Grassley — which will enhance critical data sharing between distributors and the DEA, as well as state regulatory agencies and local law enforcement. Importantly, these provisions together will provide greater visibility around the overall number of controlled substances shipped, as well as establish a more streamlined approach to reporting suspicious orders through the creation of a centralized database.

“This bill, and its two supply chain-related provisions, incorporate many of the forward-looking policy solutions that HDA and its distributor members have proposed as part of comprehensive response to the opioid crisis. We urge the Senate and House to act quickly to reach consensus and send a final legislative package to the White House. We look forward to continuing our work with legislators to ensure that these policy changes effectively improve coordination and communication with the DEA and distributors.”

ABOUT THE HEALTHCARE DISTRIBUTION ALLIANCE

The Healthcare Distribution Alliance (HDA) represents primary pharmaceutical distributors — the vital link between the nation’s pharmaceutical manufacturers and more than 200,000 pharmacies, hospitals, long-term care facilities, clinics and others nationwide. Since 1876, HDA has helped members navigate regulations and innovations to get the right medicines to the right patients at the right time, safely and efficiently. The HDA Research Foundation, HDA’s non-profit charitable foundation, serves the healthcare industry by providing research and education focused on priority healthcare supply chain issues.

CONTACT

Website design and development by Americaneagle.com, inc
© 2018 Healthcare Distribution Alliance. All rights reserved.
HDA: M | C | D | NF | P | O365